With reference to the subject cited above the Board of Directors of the Company at their meeting held today (i.e., February 11, 2026) has inter-alia, approved the unaudited financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Healthy Investments Ltd's Board, at its meeting on February 11, 2026, approved the unaudited financial results for Q3 FY26 (quarter ended Dec 31, 2025) and the nine-month period. Revenue from operations for 9M FY26 stood at ₹1.467 million, down from ₹2.042 million in 9M FY25 — a decline of about 28%. Q3 revenue rose sharply to ₹0.913 million from ₹0.239 million a year ago, on a low base. The company swung to a small 9M profit of ₹0.097 million versus a loss of ₹9.054 million last year, though Q3 alone remained marginally negative at ₹(0.391) million. Statutory auditors Narasimha Rao & Associates issued an unqualified limited review report. The company operates in a single segment — Portfolio Investments — and reported no debt defaults.
The nine-month loss has largely been recovered, but revenue is still shrinking year-on-year and the latest quarter remains in the red, suggesting limited operating momentum. For shareholders, this is a small, thinly-traded investment company with a tiny share base (~₹2.45 million paid-up capital), so results may not materially move the stock but show a modest turnaround from the prior year's large losses.